Association of the MTHFR gene with Antipsychotic-induced Metabolic Abnormalities in Patients with Schizophrenia
Authors:
- 7 June 2012
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 13 (8) , 843-846
Abstract
No abstract availableFunding Information
- Genetics of antipsychotics-induced metabolic syndrome (MOP 89853)
This publication has 19 references indexed in Scilit:
- Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implicationsMolecular Psychiatry, 2011
- MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational studyInternational Clinical Psychopharmacology, 2010
- MTHFR and risk of metabolic syndrome in patients with schizophreniaSchizophrenia Research, 2010
- Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variantsSchizophrenia Research, 2008
- A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertensionEuropean Journal of Human Genetics, 2007
- Environmental epigenomics and disease susceptibilityNature Reviews Genetics, 2007
- Our ReviewersThe Journal of Clinical Psychiatry, 2004
- Facts and Recommendations about Total Homocysteine Determinations: An Expert OpinionClinical Chemistry, 2004
- MTHFR 677C→T Polymorphism and Risk of Coronary Heart DiseaseJAMA, 2002
- Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductaseProceedings of the National Academy of Sciences, 2001